The fourth five-year: Grows by leaps and bounds with promising future(from 2018 until now)
At the end of 2018, the Company opened the TRAUER franchise store in Tmall, setting up the e-commerce platform to sell medical devices.
In September 2019, the company was certified to use industrial site in Guangzhou Sino-Singapore Knowledge City and commenced the construction of the new workplace.
From 2020 to 2021, the company was selected as a provincial/national 'small giant' enterprise with professionalism, refinement, uniqueness and novelty, a private leading enterprise in Guangzhou, and a postdoctoral innovation practice base in Guangzhou.
In 2019 and 2021, Xinyu Chuangjin Biomedical Technology Co. Ltd. and Hangzhou Branch of Guangzhou Trauemy Biotechnology Co. Ltd. were set up respectively in order to “go global” in production and e-commerce.
By 2022, Xinyu Chuangjin has obtained 9 Type I medical device products and 4 Type II medical device products registration certificates and achieved mass production, and Hangzhou Branch set up a new record in e-commerce with sales over 13 million RMB in one day during the anniversary sales promotion, .
In 2022, the construction of the new working site was completed and accepted.
With twenty years of efforts on technology and marketing channel arrangement, the company advanced into a rapid development stage. During this period, the range of product is more abundant, with a large-scale and systematic capacity for R&D, production and sales of active collagen raw materials, medical devices and bio-skin care products.